Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Henning Willers, M.D.

Co-Author

This page shows the publications co-authored by Henning Willers and Kathryn Held.
Connection Strength

1.397
  1. Introduction to clinical radiation biology. Hematol Oncol Clin North Am. 2006 Feb; 20(1):1-24.
    View in: PubMed
    Score: 0.336
  2. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019 Mar; 46(3):e53-e78.
    View in: PubMed
    Score: 0.207
  3. Effects of Charged Particles on Human Tumor Cells. Front Oncol. 2016; 6:23.
    View in: PubMed
    Score: 0.168
  4. Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):78-85.
    View in: PubMed
    Score: 0.168
  5. Lung cancer cell line screen links fanconi anemia/BRCA pathway defects to increased relative biological effectiveness of proton radiation. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1081-9.
    View in: PubMed
    Score: 0.159
  6. Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers. Mol Cancer Res. 2015 Apr; 13(4):713-20.
    View in: PubMed
    Score: 0.157
  7. FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditions. Int J Radiat Biol. 2009 Jun; 85(6):523-31.
    View in: PubMed
    Score: 0.106
  8. Biomarkers and mechanisms of FANCD2 function. J Biomed Biotechnol. 2008; 2008:821529.
    View in: PubMed
    Score: 0.096
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.